NASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis → The Military's $700M 'AI Software Bullet' (From Behind the Markets) (Ad) Free RMTI Stock Alerts $1.84 -0.01 (-0.54%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$1.72▼$1.8850-Day Range$1.45▼$1.9252-Week Range$1.16▼$6.24Volume688,181 shsAverage Volume203,075 shsMarket Capitalization$55.94 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Rockwell Medical alerts: Email Address Rockwell Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside279.4% Upside$7.00 Price TargetShort InterestHealthy2.28% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment1.47Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.14) to $0.04 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.93 out of 5 starsMedical Sector192nd out of 913 stocksPharmaceutical Preparations Industry81st out of 429 stocks 3.5 Analyst's Opinion Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRockwell Medical has only been the subject of 1 research reports in the past 90 days.Read more about Rockwell Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.28% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently increased by 6.51%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.Environmental SustainabilityThe Environmental Impact score for Rockwell Medical is -2.35. Previous Next 4.1 News and Social Media Coverage News SentimentRockwell Medical has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Rockwell Medical this week, compared to 1 article on an average week.Search Interest4 people have searched for RMTI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows2 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.90% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 23.31% of the stock of Rockwell Medical is held by institutions.Read more about Rockwell Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Rockwell Medical are expected to grow in the coming year, from ($0.14) to $0.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -5.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -5.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Rockwell Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About Rockwell Medical Stock (NASDAQ:RMTI)Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.Read More RMTI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RMTI Stock News HeadlinesJune 14 at 2:36 AM | americanbankingnews.comRockwell Medical (NASDAQ:RMTI) Shares Pass Above 200 Day Moving Average of $1.60May 30, 2024 | businesswire.comRockwell Medical Promotes Tim Chole to Chief Commercial OfficerMay 16, 2024 | markets.businessinsider.comRockwell Medical: Strong Financial Performance and Strategic Partnerships Justify Buy RatingMay 15, 2024 | msn.comRockwell Medical, Inc. (NASDAQ:RMTI) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comRockwell Medical Inc (RMTI) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 15, 2024 | finance.yahoo.comQ1 2024 Rockwell Medical Inc Earnings CallMay 14, 2024 | markets.businessinsider.comRockwell Medical is about to announce its earnings — here's what to expectMay 14, 2024 | investorplace.comRMTI Stock Earnings: Rockwell Medical Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | msn.comRockwell Medical Non-GAAP EPS of -$0.02, revenue of $22.7M beats by $1MMay 14, 2024 | businesswire.comRockwell Medical Announces First Quarter 2024 Results, Raises 2024 GuidanceMay 13, 2024 | msn.comRockwell Medical Q1 Earnings PreviewApril 21, 2024 | finance.yahoo.comRockwell Medical, Inc. (RMTI)April 17, 2024 | finance.yahoo.comRockwell Medical Continues to Expand its Distribution Capabilities in Western United StatesApril 16, 2024 | businesswire.comRockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024April 4, 2024 | msn.comRockwell Medical gains as global reach widensApril 4, 2024 | businesswire.comRockwell Medical Expands Global Distribution in the Dominican Republic and BermudaMarch 26, 2024 | finance.yahoo.comRockwell Medical Full Year 2023 Earnings: EPS Beats ExpectationsMarch 25, 2024 | businesswire.comRockwell Medical Named 'Great Place to Work' for Second Year in a RowMarch 24, 2024 | finance.yahoo.comAnalysts Have Been Trimming Their Rockwell Medical, Inc. (NASDAQ:RMTI) Price Target After Its Latest ReportMarch 23, 2024 | seekingalpha.comRockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Rockwell Med amidst Strategic Growth and Operational EfficiencyMarch 22, 2024 | finance.yahoo.comQ4 2023 Rockwell Medical Inc Earnings CallMarch 21, 2024 | benzinga.comRockwell Medical: Q4 Earnings InsightsMarch 21, 2024 | marketwatch.comRockwell Medical Shares Rise After Narrower 4Q Loss, Higher SalesMarch 21, 2024 | msn.comRMTI Stock Earnings: Rockwell Medical Beats EPS, Misses Revenue for Q4 2023See More Headlines Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/17/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CUSIP77437410 CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees237Year Founded1995Price Target and Rating Average Stock Price Target$7.00 High Stock Price Target$9.00 Low Stock Price Target$5.00 Potential Upside/Downside+279.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,440,000.00 Net Margins-9.72% Pretax Margin-9.72% Return on Equity-28.29% Return on Assets-10.67% Debt Debt-to-Equity Ratio0.47 Current Ratio1.79 Quick Ratio1.38 Sales & Book Value Annual Sales$83.61 million Price / Sales0.67 Cash Flow$0.02 per share Price / Cash Flow95.31 Book Value$0.75 per share Price / Book2.46Miscellaneous Outstanding Shares30,320,000Free Float29,740,000Market Cap$55.94 million OptionableOptionable Beta1.28 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Mark Strobeck Ph.D. (Age 53)President, CEO & Director Comp: $904.66kMr. Jesse Neri (Age 46)Senior Vice President of Finance Comp: $359.63kMs. Megan C. Timmins (Age 51)Executive VP, Chief Legal Officer & Secretary Comp: $585.74kMr. James A. McCarthySenior Vice President of Business & Corporate DevelopmentMr. Timothy T. CholeSenior Vice President of Sales & MarketingMs. Heather R. HunterSenior VP & Chief Corporate Affairs OfficerMr. Jason FinkelsteinInvestor Relations RepresentativeMore ExecutivesKey CompetitorselectroCoreNASDAQ:ECORIRIDEXNASDAQ:IRIXFONARNASDAQ:FONRAccurayNASDAQ:ARAYReShape LifesciencesNASDAQ:RSLSView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 43,302 shares on 5/10/2024Ownership: 3.808%Richmond Brothers Inc.Sold 90,182 shares on 5/10/2024Ownership: 1.097%SkyOak Wealth LLCBought 8,065 shares on 4/30/2024Ownership: 0.086%View All Institutional Transactions RMTI Stock Analysis - Frequently Asked Questions Should I buy or sell Rockwell Medical stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RMTI shares. View RMTI analyst ratings or view top-rated stocks. What is Rockwell Medical's stock price target for 2024? 2 Wall Street analysts have issued 12-month price targets for Rockwell Medical's shares. Their RMTI share price targets range from $5.00 to $9.00. On average, they expect the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 279.4% from the stock's current price. View analysts price targets for RMTI or view top-rated stocks among Wall Street analysts. How have RMTI shares performed in 2024? Rockwell Medical's stock was trading at $1.89 at the start of the year. Since then, RMTI shares have decreased by 2.4% and is now trading at $1.8450. View the best growth stocks for 2024 here. When is Rockwell Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our RMTI earnings forecast. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) posted its earnings results on Tuesday, May, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.03. The business had revenue of $22.68 million for the quarter, compared to analysts' expectations of $21.18 million. Rockwell Medical had a negative trailing twelve-month return on equity of 28.29% and a negative net margin of 9.72%. During the same period in the previous year, the firm posted ($0.10) EPS. When did Rockwell Medical's stock split? Rockwell Medical shares reverse split on the morning of Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. What guidance has Rockwell Medical issued on next quarter's earnings? Rockwell Medical issued an update on its FY 2024 earnings guidance on Tuesday, May, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $90.0 million-$94.0 million, compared to the consensus revenue estimate of $89.0 million. What is Robert L. Chioini's approval rating as Rockwell Medical's CEO? 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV). Who are Rockwell Medical's major shareholders? Rockwell Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.81%), Richmond Brothers Inc. (1.10%) and SkyOak Wealth LLC (0.09%). View institutional ownership trends. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RMTI) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.